HealthEquity, Inc (HQY) is a publicly traded Healthcare sector company. As of May 21, 2026, HQY trades at $87.51 with a market cap of $6.96B and a P/E ratio of 38.91. HQY moved +3.41% today. Year to date, HQY is -6.33%; over the trailing twelve months it is -13.47%. Its 52-week range spans $72.76 to $116.65. Analyst consensus is strong buy with an average price target of $114.40. Rallies surfaces HQY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded HQY stock?
Recent politician trading activity in HQY includes disclosures from Gilbert Cisneros and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
HQY Key Metrics
Key financial metrics for HQY
Metric
Value
Price
$87.51
Market Cap
$6.96B
P/E Ratio
38.91
EPS
$2.21
Dividend Yield
0.00%
52-Week High
$116.65
52-Week Low
$72.76
Volume
1.08M
Avg Volume
0
Revenue (TTM)
$1.29B
Net Income
$191.83M
Gross Margin
67.72%
Congressional Trades in HQY
Gilbert Cisneros sale HQY on Jun 16, 2025 (amount: $15.00K).
Josh Gottheimer sale HQY on Jun 21, 2024 (amount: $15.00K) for Joint.
Recent politician trading activity in HQY includes disclosures from Gilbert Cisneros and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in HQY?
Yes. Rallies tracks politician and congressional stock disclosures for HQY, including reported purchases, sales, dates, owners, and trade amounts when available.
Is HQY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HQY. It does not provide personalized investment advice.
